PHARMACYCLICS INC Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q3 FY2013 As of Sep 30, 2013	Q2 FY2013 As of Jun 30, 2013	Q1 FY2013 As of Mar 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q3 FY2012 As of Sep 30, 2012	Q2 FY2012 As of Jun 30, 2012	Q1 FY2012 As of Mar 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q3 FY2011 As of Sep 30, 2011
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Receivable from collaboration partners
Inventory
Advances to manufacturers
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Payable to collaboration partner
Income tax payable
Deferred revenue - current portion
Total current liabilities
Deferred revenue - non-current portion
Deferred rent
Other long-term liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2015 and December 31, 2014, respectively; shares issued and outstanding 76,791,635 and 75,933,661 at March 31, 2015 and December 31, 2014, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Deficit accumulated during development stage
Accumulated deficit
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments